AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
EVMN vs EVH Fundamental Comparison
| Metric | EVMN | EVH |
|---|---|---|
| Revenue | $13.0M | $1.9B |
| Net Income | $-68.9M | $-534.5M |
| Net Margin | -529.8% | -28.5% |
| ROE | -33.5% | -128.7% |
| ROA | -30.6% | -28.1% |
| Current Ratio | 8.57x | 1.31x |
| Debt/Equity | 0.00x | 2.34x |
| EPS | $-11.22 | $-5.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVMN vs EVH: Frequently Asked Questions
Is EVMN or EVH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. EVMN is rated STRONG SELL (92% confidence) while EVH is rated STRONG SELL (92% confidence). This is not investment advice.
How does EVMN compare to EVH fundamentally?
Evommune, Inc. has ROE of -33.5% vs Evolent Health, Inc.'s -128.7%. Net margins are -529.8% vs -28.5% respectively.
Which stock pays higher dividends, EVMN or EVH?
EVMN has a dividend yield of N/A or no dividend while EVH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVMN or EVH for long term?
For long-term investing, consider that EVMN has STRONG SELL rating with 92% confidence, while EVH has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVMN vs EVH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVMN vs EVH, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.